|A non-pneumatic anti-shock garment (NASG)|
|Specialty||Critical care medicine|
|Symptoms||Initial: Weakness, fast heart rate, fast breathing, sweating, anxiety, increased thirst|
Later: Confusion, unconsciousness, cardiac arrest
|Types||Low volume, cardiogenic, obstructive, distributive|
|Causes||Low volume: Bleeding, vomiting, pancreatitis|
Cardiogenic: heart attack, cardiac contusion
Obstructive: Cardiac tamponade, tension pneumothorax
Distributive: Sepsis, spinal cord injury, certain overdoses
|Diagnostic method||Based on symptoms, physical exam, laboratory tests|
|Treatment||Based on the underlying cause|
|Medication||Intravenous fluid, vasopressors|
|Prognosis||Risk of death 20 to 50%|
|Frequency||1.2 million per year (US)|
Shock is the state of insufficient blood flow to the tissues of the body as a result of problems with the circulatory system. Initial symptoms of shock may include weakness, fast heart rate, fast breathing, sweating, anxiety, and increased thirst. This may be followed by confusion, unconsciousness, or cardiac arrest, as complications worsen.
Shock is divided into four main types based on the underlying cause: low volume, cardiogenic, obstructive, and distributive shock. Low volume shock, also known as hypovolemic shock, may be from bleeding, diarrhea, or vomiting. Cardiogenic shock may be due to a heart attack or cardiac contusion. Obstructive shock may be due to cardiac tamponade or a tension pneumothorax. Distributive shock may be due to sepsis, anaphylaxis, injury to the upper spinal cord, or certain overdoses.
The diagnosis is generally based on a combination of symptoms, physical examination, and laboratory tests. A decreased pulse pressure (systolic blood pressure minus diastolic blood pressure) or a fast heart rate raises concerns. The heart rate divided by systolic blood pressure, known as the shock index (SI), of greater than 0.8 supports the diagnosis more than low blood pressure or a fast heart rate in isolation.
Treatment of shock is based on the likely underlying cause. An open airway and sufficient breathing should be established. Any ongoing bleeding should be stopped, which may require surgery or embolization. Intravenous fluid, such as Ringer's lactate or packed red blood cells, is often given. Efforts to maintain a normal body temperature are also important. Vasopressors may be useful in certain cases. Shock is both common and has a high risk of death. In the United States about 1.2 million people present to the emergency room each year with shock and their risk of death is between 20 and 50%.
Signs and symptoms
The presentation of shock is variable, with some people having only minimal symptoms such as confusion and weakness. While the general signs for all types of shock are low blood pressure, decreased urine output, and confusion, these may not always be present. While a fast heart rate is common, those on β-blockers, those who are athletic, and in 30% of cases of those with shock due to intra abdominal bleeding may have a normal or slow heart rate. Specific subtypes of shock may have additional symptoms.
Hypovolemic shock is the most common type of shock and is caused by insufficient circulating volume. The most common cause of hypovolemic shock is hemorrhage (internal or external); however, vomiting and diarrhea are the most common cause in children. Other causes include burns, as well as excess urine loss due to diabetic ketoacidosis and diabetes insipidus.
|Class||Blood loss (liters)||Response||Treatment|
|I||<15% (0.75 l)||min. fast heart rate, normal blood pressure||minimal|
|II||15–30% (0.75–1.5 l)||fast heart rate, min. low blood pressure||intravenous fluids|
|III||30–40% (1.5–2 l)||very fast heart rate, low blood pressure, confusion||fluids and packed RBCs|
|IV||>40% (>2 l)||critical blood pressure and heart rate||aggressive interventions|
Signs and symptoms of hypovolemic shock include:
- A rapid, weak, thready pulse due to decreased blood flow combined with tachycardia
- Cool skin due to vasoconstriction and stimulation of vasoconstriction
- Rapid and shallow breathing due to sympathetic nervous system stimulation and acidosis
- Hypothermia due to decreased perfusion and evaporation of sweat
- Thirst and dry mouth, due to fluid depletion
- Cold and mottled skin (Livedo reticularis), especially extremities, due to insufficient perfusion of the skin
The severity of hemorrhagic shock can be graded on a 1–4 scale on the physical signs. The shock index (heart rate divided by systolic blood pressure) is a stronger predictor of the impact of blood loss than heart rate and blood pressure alone. This relationship has not been well established in pregnancy-related bleeding.
Cardiogenic shock is caused by the failure of the heart to pump effectively. This can be due to damage to the heart muscle, most often from a large myocardial infarction. Other causes of cardiogenic shock include dysrhythmias, cardiomyopathy/myocarditis, congestive heart failure (CHF), myocardial contusion, or valvular heart disease problems.
Symptoms of cardiogenic shock include:
- Distended jugular veins due to increased jugular venous pressure
- Weak or absent pulse
- Abnormal heart rhythms, often a fast heart rate
- Pulsus paradoxus in case of tamponade
- Reduced blood pressure
- Shortness of breath, due to pulmonary congestion
- Cardiac tamponade in which fluid in the pericardium prevents inflow of blood into the heart (venous return). Constrictive pericarditis, in which the pericardium shrinks and hardens, is similar in presentation.
- Tension pneumothorax Through increased intrathoracic pressure, bloodflow to the heart is prevented (venous return).
- Pulmonary embolism is the result of a thromboembolic incident in the blood vessels of the lungs and hinders the return of blood to the heart.
- Aortic stenosis hinders circulation by obstructing the ventricular outflow tract
- Hypertrophic sub-aortic stenosis is overly thick ventricular muscle that dynamically occludes the ventricular outflow tract.
- Abdominal compartment syndrome defined as an increase in intra-abdominal pressure to > 20 mmHg with organ dysfunction. Increased intraabdominal pressure can be due to sepsis and severe abdominal trauma. This increased pressure reduced blood flow back to the heart, thereby reducing blood flow to the body and resulting in signs and symptoms of shock.
Many of the signs of obstructive shock are similar to cardiogenic shock, however treatments differ. Symptoms of obstructive shock include:
- Abnormal heart rhythms, often a fast heart rate.
- Reduced blood pressure.
- Cool, clammy, mottled skin, often due to low blood pressure and vasoconstriction.
- Decreased urine output.
|Temperature||<36 °C (96.8 °F) or >38 °C (100.4 °F)|
|Respiratory rate||>20/min or PaCO2<32 mmHg (4.3 kPa)|
|WBC||<4x109/L (<4000/mm3), >12x109/L (>12,000/mm3), or ≥10% bands|
Distributive shock is low blood pressure due to a dilation of blood vessels within the body. This can be caused by systemic infection (septic shock), a severe allergic reaction (anaphylaxis), or spinal cord injury (neurogenic shock).
- Septic shock is the most common cause of distributive shock. It is caused by an overwhelming systemic infection resulting in vasodilation leading to hypotension. Septic shock can be caused by Gram negative bacteria such as (among others) Escherichia coli, Proteus species, Klebsiella pneumoniae which have an endotoxin on their surface which produces adverse biochemical, immunological and occasionally neurological effects which are harmful to the body, and other Gram-positive cocci, such as pneumococci and streptococci, and certain fungi as well as Gram-positive bacterial toxins. Septic shock also includes some elements of cardiogenic shock. In 1992, the ACCP/SCCM Consensus Conference Committee defined septic shock: " … sepsis-induced hypotension (systolic blood pressure < 90 mmHg or a reduction of 40 mmHg from baseline) despite adequate fluid resuscitation along with the presence of perfusion abnormalities that may include, but are not limited to, lactic acidosis, oliguria, or an acute alteration in mental status. Patients who are receiving inotropic or vasopressor agents may have a normalized blood pressure at the time that perfusion abnormalities are identified. The pathophysiology behind septic shock is as follows: 1) Systemic leukocyte adhesion to endothelial cells 2) Reduced contractility of the heart 3) Activation of the coagulation pathways, resulting in disseminated intravascular coagulation 4). Increased levels of neutrophils
- The main manifestations of septic shock are due to the massive release of histamine which causes intense dilation of the blood vessels. People with septic shock will also likely be positive for SIRS criteria. The most generally accepted treatment for these patients is early recognition of symptoms, and early administration of broad spectrum and organism specific antibiotics.
- Signs of septic shock include:
- Anaphylactic shock is caused by a severe anaphylactic reaction to an allergen, antigen, drug or foreign protein causing the release of histamine which causes widespread vasodilation, leading to hypotension and increased capillary permeability.
- High spinal injuries may cause neurogenic shock, which is commonly classified as a subset of distributive shock. The classic symptoms include a slow heart rate due to loss of cardiac sympathetic tone and warm skin due to dilation of the peripheral blood vessels. (This term can be confused with spinal shock which is a recoverable loss of function of the spinal cord after injury and does not refer to the hemodynamic instability.)
Although not officially classified as a subcategory of shock, many endocrinology disturbances in their severe form can result in shock.
- Hypothyroidism (can be considered a form of cardiogenic shock) in people who are critically ill patients, reduces cardiac output and can lead to hypotension and respiratory insufficiency.
- Thyrotoxicosis (cardiogenic shock) may induce a reversible cardiomyopathy.
- Acute adrenal insufficiency (distributive shock) is frequently the result of discontinuing corticosteroid treatment without tapering the dosage. However, surgery and intercurrent disease in patients on corticosteroid therapy without adjusting the dosage to accommodate for increased requirements may also result in this condition.
- Relative adrenal insufficiency (distributive shock) in critically ill patients where present hormone levels are insufficient to meet the higher demands
|Low volume||Fluid loss such as bleeding or diarrhea|
|Heart||Ineffective pumping due to heart damage|
|Obstructive||Blood flow to or from the heart is blocked|
|Distributive||Due to abnormal flow within the small blood vessels|
Shock is a common end point of many medical conditions. Shock itself is a life-threatening condition as a result of compromised body circulation. It can be divided into four main types based on the underlying cause: hypovolemic, distributive, cardiogenic, and obstructive. A few additional classifications are occasionally used, such as endocrinologic shock.
There are four stages of shock. Shock is a complex and continuous condition, and there is no sudden transition from one stage to the next. At a cellular level, shock is the process of oxygen demand becoming greater than oxygen supply.
One of the key dangers of shock is that it progresses by a positive feedback mechanism. Poor blood supply leads to cellular damage, which results in an inflammatory response to increase blood flow to the affected area. In this manner, the blood supply level is matched with tissue demand for nutrients. However, if there is enough increased demand in some areas, it can deprive other areas of sufficient supply. Due to this chain of events, immediate treatment of shock is critical for survival.
During this stage, the state of hypoperfusion causes hypoxia. Due to the lack of oxygen, the cells perform lactic acid fermentation. Since oxygen, the terminal electron acceptor in the electron transport chain, is not abundant, this slows down entry of pyruvate into the Krebs cycle, resulting in its accumulation. The accumulating pyruvate is converted to lactate by lactate dehydrogenase. The accumulating lactate causes lactic acidosis.
This stage is characterised by the body employing physiological mechanisms, including neural, hormonal and bio-chemical mechanisms, in an attempt to reverse the condition. As a result of the acidosis, the person will begin to hyperventilate in order to rid the body of carbon dioxide (CO2). CO2 indirectly acts to acidify the blood, so the body attempts to return to acid–base homeostasis by removing that acidifying agent. The baroreceptors in the arteries detect the hypotension resulting from large amounts of blood being redirected to distant tissues, and cause the release of epinephrine and norepinephrine. Norepinephrine causes predominately vasoconstriction with a mild increase in heart rate, whereas epinephrine predominately causes an increase in heart rate with a small effect on the vascular tone; the combined effect results in an increase in blood pressure. The renin–angiotensin axis is activated, and arginine vasopressin (anti-diuretic hormone) is released to conserve fluid by reducing its excretion via the renal system. These hormones cause the vasoconstriction of the kidneys, gastrointestinal tract, and other organs to divert blood to the heart, lungs and brain. The lack of blood to the renal system causes the characteristic low urine production. However the effects of the renin–angiotensin axis take time and are of little importance to the immediate homeostatic mediation of shock.
In the absence of successful treatment of the underlying cause, shock will proceed to the progressive stage. During this stage, compensatory mechanisms begin to fail. Due to the decreased perfusion of the cells in the body, sodium ions build up within the intracellular space while potassium ions leak out. Due to lack of oxygen, cellular respiration diminishes and anaerobic metabolism predominates. As anaerobic metabolism continues, a metabolic acidosis, the arteriolar smooth muscle and precapillary sphincters relax such that blood remains in the capillaries. Due to this, the hydrostatic pressure will increase and, combined with histamine release, this will lead to leakage of fluid and protein into the surrounding tissues. As this fluid is lost, the blood concentration and viscosity increase, causing sludging of the micro-circulation. The prolonged vasoconstriction will also cause the vital organs to be compromised due to reduced perfusion. If the bowel becomes sufficiently ischemic, bacteria may enter the blood stream, resulting in the increased complication of endotoxic shock.
At this stage, the vital organs have failed and the shock can no longer be reversed. Brain damage and cell death are occurring, and death will occur imminently. One of the primary reasons that shock is irreversible at this point is that much cellular ATP has been degraded into adenosine in the absence of oxygen as an electron receptor in the mitochondrial matrix. Adenosine easily perfuses out of cellular membranes into extracellular fluid, furthering capillary vasodilation, and then is transformed into uric acid. Because cells can only produce adenosine at a rate of about 2% of the cell's total need per hour, even restoring oxygen is futile at this point because there is no adenosine to phosphorylate into ATP.
The diagnosis of shock is commonly based on a combination of symptoms, physical examination, and laboratory tests. Many signs and symptoms are not sensitive or specific for shock, and as such many clinical decision making tools have been developed to identify shock at an early stage. A high degree of suspicion is necessary for the proper diagnosis of shock.
The first change seen in shock is increased cardiac output followed by a decrease in mixed venous oxygen saturation (SmvO2) as measured in the pulmonary artery via a pulmonary artery catheter. Central venous oxygen saturation (ScvO2) as measured via a central line correlates well with SmvO2 and are easier to acquire. If shock progresses anaerobic metabolism will begin to occur with an increased blood lactic acid as the result. While many laboratory tests are typically performed, there is no test that either makes or excludes the diagnosis. A chest X-ray or emergency department ultrasound may be useful to determine volume status.
The best evidence exists for the treatment of septic shock in adults. However, the pathophysiology of shock appears similar in children, and treatment methodologies have been extrapolated to children. Management may include securing the airway via intubation if necessary to decrease the work of breathing and for guarding against respiratory arrest. Oxygen supplementation, intravenous fluids, passive leg raising (not Trendelenburg position) should be started and blood transfusions added if blood loss is severe. It is important to keep the person warm to avoid hypothermia as well as adequately manage pain and anxiety as these can increase oxygen consumption. Negative impact by shock is reversible if it's recognized and treated early in time.
Aggressive intravenous fluids are recommended in most types of shock (e.g. 1–2 liter normal saline bolus over 10 minutes or 20 ml/kg in a child) which is usually instituted as the person is being further evaluated. Colloids and crystalloids appear to be similar with respect to outcomes., Balanced crystalloids and normal saline also appear to be similar in critically ill patients. If the person remains in shock after initial resuscitation, packed red blood cells should be administered to keep the hemoglobin greater than 100 g/l.
For those with hemorrhagic shock, the current evidence supports limiting the use of fluids for penetrating thorax and abdominal injuries allowing mild hypotension to persist (known as permissive hypotension). Targets include a mean arterial pressure of 60 mmHg, a systolic blood pressure of 70–90 mmHg, or until their adequate mentation and peripheral pulses. Hypertonic fluid may also be an option in this group.
There is no evidence of substantial benefit of one vasopressor over another; however, using dopamine leads to an increased risk of arrhythmia when compared with norepinephrine. Vasopressors have not been found to improve outcomes when used for hemorrhagic shock from trauma but may be of use in neurogenic shock. Activated protein C (Xigris) while once aggressively promoted for the management of septic shock has been found not to improve survival and is associated with a number of complications. Activated protein C was withdrawn from the market in 2011, and clinical trials were discontinued. The use of sodium bicarbonate is controversial as it has not been shown to improve outcomes. If used at all it should only be considered if the pH is less than 7.0.
People with anaphylactic shock are commonly treated with epinephrine. Antihistamines, such as benadryl, diphenhydramine and ranitidine are also commonly administered. Albuterol, normal saline, and steroids are also commonly given.
- Intra-aortic balloon pump (IABP) – a device inserted into the aorta that mechanically raises the blood pressure. Use of Intra-aortic balloon pumps is not recommended in cardiogenic shock.
- Ventricular assist device (VAD) – A mechanical pump that helps pump blood throughout the body. Commonly used in short term cases of refractory primary cardiogenic shock.
- Artificial heart (TAH)
- Extracorporeal membrane oxygenation (ECMO) – an external device that completely replaces the work of the heart.
The goal of treatment is to achieve a urine output of greater than 0.5 ml/kg/h, a central venous pressure of 8–12 mmHg and a mean arterial pressure of 65–95 mmHg. In trauma the goal is to stop the bleeding which in many cases requires surgical interventions. A good urine output indicates that the kidneys are getting enough blood flow.
Septic shock (a form of distributive shock), is the most common form of shock. Shock from blood loss occurs in about 1–2% of trauma cases. Up to one-third of people admitted to the intensive care unit (ICU) are in circulatory shock. Of these, cardiogenic shock accounts for approximately 20%, hypovolemic about 20%, and septic shock about 60% of cases.
The prognosis of shock depends on the underlying cause and the nature and extent of concurrent problems. Low volume, anaphylactic, and neurogenic shock are readily treatable and respond well to medical therapy. Septic shock, however has a mortality rate between 30% and 80% while cardiogenic shock has a mortality rate between 70% and 90%.
There is no evidence of the word shock being used in its modern-day form prior to 1743. However, there is evidence that Hippocrates used the word exemia to signify a state of being “drained of blood". Shock or "choc" was first described in a trauma victim in the English translation of Henri-François LeDran's 1740 text, Traité ou Reflexions Tire'es de la Pratique sur les Playes d'armes à feu (A treatise, or reflections, drawn from practice on gun-shot wounds.) In this text he describes "choc" as a reaction to the sudden impact of a missile. However, the first English writer to use the word shock in its modern-day connotation was James Latta, in 1795.
Prior to World War I, there were several competing hypotheses behind the pathophysiology of shock. Of the various theories, the most well regarded was a theory penned by George W. Crile who in 1899 suggested in his monograph, "An Experimental Research into Surgical Shock", that shock was quintessentially defined as a state of circulatory collapse (vasodilation) due to excessive nervous stimulation. Other competing theories around the turn of the century included one penned by Malcolm in 1905, in which the assertion was that prolonged vasoconstriction led to the pathophysiological signs and symptoms of shock. In the following World War I, research around shock resulted in experiments by Walter B. Cannon of Harvard and William M. Bayliss of London in 1919 that showed that an increase in permeability of the capillaries in response to trauma or toxins was responsible for many clinical manifestations of shock. In 1972 Hinshaw and Cox suggested the classification system for shock which is still used today.
- International Trauma Life Support for Emergency Care Providers (8 ed.). Pearson Education Limited. 2018. pp. 172–73. ISBN 978-1292-17084-8.
- ATLS – Advanced Trauma Life Support – Student Course Manual (10 ed.). American College of Surgeons. 2018. pp. 43–52, 135. ISBN 978-78-0-9968267.
- Tabas, Jeffrey; Reynolds, Teri (2010). High Risk Emergencies, An Issue of Emergency Medicine Clinics (E-book). Elsevier Health Sciences. p. 58. ISBN 978-1455700257.
- Smith, N; Lopez, RA; Silberman, M (January 2019). "Distributive Shock". PMID 29261964. Cite journal requires
- Olaussen A, Blackburn T, Mitra B, Fitzgerald M (June 2014). "Review article: shock index for prediction of critical bleeding post-trauma: a systematic review". Emergency Medicine Australasia. 26 (3): 223–28. doi:10.1111/1742-6723.12232. PMID 24712642. S2CID 19881753.
- Guyton, Arthur; Hall, John (2006). "Chapter 24: Circulatory Shock and Physiology of Its Treatment". In Gruliow, Rebecca (ed.). Textbook of Medical Physiology (11th ed.). Philadelphia, Pennsylvania: Elsevier Inc. pp. 278–88. ISBN 978-0-7216-0240-0.
- Tintinalli, Judith E. (2010). Emergency Medicine: A Comprehensive Study Guide. New York: McGraw-Hill Companies. pp. 165–72. ISBN 978-0-07-148480-0.
- Tintinalli, Judith E. (2010). Emergency Medicine: A Comprehensive Study Guide. New York: McGraw-Hill Companies. pp. 174–75. ISBN 978-0-07-148480-0.
- Assessing dehydration and shock. NCBI Bookshelf. National Collaborating Centre for Women's and Children's Health (UK). Retrieved 2019-05-09.
- Silverman, Adam (Oct 2005). "Shock: A Common Pathway For Life-Threatening Pediatric Illnesses And Injuries". Pediatric Emergency Medicine Practice. 2 (10).
- Tintinalli, Judith E. (2010). Emergency Medicine: A Comprehensive Study Guide. New York: McGraw-Hill Companies. ISBN 978-0-07-148480-0.
- Pacagnella RC, Souza JP, Durocher J, Perel P, Blum J, Winikoff B, Gülmezoglu AM (2013). "A systematic review of the relationship between blood loss and clinical signs". PLOS ONE. 8 (3): e57594. Bibcode:2013PLoSO...857594P. doi:10.1371/journal.pone.0057594. PMC 3590203. PMID 23483915.
- Pich, H.; Heller, A.R. (May 2015). "Obstruktiver Schock". Der Anaesthesist (in German). 64 (5): 403–19. doi:10.1007/s00101-015-0031-9. ISSN 0003-2417. PMID 25994928. S2CID 39461027.
- Cheatham, Michael Lee (April 2009). "Abdominal compartment syndrome". Current Opinion in Critical Care. 15 (2): 154–62. doi:10.1097/MCC.0b013e3283297934. ISSN 1531-7072. PMID 19276799. S2CID 42407737.
- Cheatham, Michael L.; Malbrain, Manu L. N. G.; Kirkpatrick, Andrew; Sugrue, Michael; Parr, Michael; De Waele, Jan; Balogh, Zsolt; Leppäniemi, Ari; Olvera, Claudia; Ivatury, Rao; D'Amours, Scott (June 2007). "Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations". Intensive Care Medicine. 33 (6): 951–62. doi:10.1007/s00134-007-0592-4. ISSN 0342-4642. PMID 17377769. S2CID 10770608.
- Bone RC, Balk RA, et al. (The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine) (June 1992). "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis". Chest. 101 (6): 1644–55. doi:10.1378/chest.101.6.1644. PMID 1303622.
- Isaac, Jeff. (2013). Wilderness and rescue medicine. Jones & Bartlett Learning. ISBN 9780763789206. OCLC 785442005.
- Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 102–103 ISBN 978-1-4160-2973-1
- "Surviving Sepsis Campaign Responds to ProCESS Trial" (PDF). Surviving Sepsis Campaign. Survivingsepsis.org. Retrieved 2015-03-25.
- Cocchi MN, Kimlin E, Walsh M, Donnino MW (August 2007). "Identification and resuscitation of the trauma patient in shock". Emergency Medicine Clinics of North America. 25 (3): 623–42, vii. CiteSeerX 10.1.1.688.9838. doi:10.1016/j.emc.2007.06.001. PMID 17826209.
- Elbers PW, Ince C (2006). "Mechanisms of critical illness – classifying microcirculatory flow abnormalities in distributive shock". Critical Care. 10 (4): 221. doi:10.1186/cc4969. PMC 1750971. PMID 16879732.
- "Definition, classification, etiology, and pathophysiology of shock in adults". UpToDate. Retrieved 2019-02-22.
- Tintinalli, Judith E. (2010). Emergency Medicine: A Comprehensive Study Guide. New York: McGraw-Hill Companies. p. 168. ISBN 978-0-07-148480-0.
- Armstrong, D.J. (2004). Shock (2nd ed.). In: Alexander, M.F., Fawcett, J.N., Runciman, P.J. Nursing Practice. Hospital and Home. The Adult.: Edinburgh: Churchill Livingstone.
- Lembke, Kelly; Parashar, Sanjay; Simpson, Steven (2017-10-01). "Sensitivity and Specificity of SIRS, qSOFA and Severe Sepsis for Mortality of Patients Presenting to the Emergency Department With Suspected Infection". Chest. 152 (4): A401. doi:10.1016/j.chest.2017.08.427. ISSN 0012-3692.
- Shoemaker, W. C. (May 1996). "Temporal physiologic patterns of shock and circulatory dysfunction based on early descriptions by invasive and noninvasive monitoring". New Horizons (Baltimore, Md.). 4 (2): 300–18. ISSN 1063-7389. PMID 8774804.
- Nolan JP, Pullinger R (March 2014). "Hypovolaemic shock". BMJ. 348 (mar07 1): g1139. doi:10.1136/bmj.g1139. PMID 24609389. S2CID 45691590.
- American College of Surgeons (2008). Atls, Advanced Trauma Life Support Program for Doctors. Amer College of Surgeons. p. 58. ISBN 978-1-880696-31-6.
- Lewis SR, Pritchard MW, Evans DJ, Butler AR, Alderson P, Smith AF, Roberts I (August 2018). "Colloids versus crystalloids for fluid resuscitation in critically ill people". The Cochrane Database of Systematic Reviews. 8: CD000567. doi:10.1002/14651858.CD000567.pub7. PMC 6513027. PMID 30073665.
- Liu, C; Lu, G; Wang, D; Lei, Y; Mao, Z; Hu, P; Hu, J; Liu, R; Han, D; Zhou, F (November 2019). "Balanced crystalloids versus normal saline for fluid resuscitation in critically ill patients: A systematic review and meta-analysis with trial sequential analysis". The American Journal of Emergency Medicine. 37 (11): 2072–78. doi:10.1016/j.ajem.2019.02.045. PMID 30852043.
- Marx, J (2010). Rosen's emergency medicine: concepts and clinical practice 7th edition. Philadelphia, PA: Mosby/Elsevier. p. 2467. ISBN 978-0-323-05472-0.
- Cherkas, David (Nov 2011). "Traumatic Hemorrhagic Shock: Advances In Fluid Management". Emergency Medicine Practice. 13 (11): 1–19, quiz 19–20. PMID 22164397. Archived from the original on 2012-01-18.
- Wu MC, Liao TY, Lee EM, Chen YS, Hsu WT, Lee MG, Tsou PY, Chen SC, Lee CC (November 2017). "Administration of Hypertonic Solutions for Hemorrhagic Shock: A Systematic Review and Meta-analysis of Clinical Trials". Anesthesia and Analgesia. 125 (5): 1549–57. doi:10.1213/ANE.0000000000002451. PMID 28930937. S2CID 39310937.
- Gamper, Gunnar; Havel, Christof; Arrich, Jasmin; Losert, Heidrun; Pace, Nathan Leon; Müllner, Marcus; Herkner, Harald (2016-02-15). "Vasopressors for hypotensive shock". The Cochrane Database of Systematic Reviews. 2: CD003709. doi:10.1002/14651858.CD003709.pub4. ISSN 1469-493X. PMC 6516856. PMID 26878401.
- Gamper G, Havel C, Arrich J, Losert H, Pace NL, Müllner M, Herkner H (February 2016). "Vasopressors for hypotensive shock". The Cochrane Database of Systematic Reviews. 2: CD003709. doi:10.1002/14651858.CD003709.pub4. PMC 6516856. PMID 26878401.
- Diez C, Varon AJ (December 2009). "Airway management and initial resuscitation of the trauma patient". Current Opinion in Critical Care. 15 (6): 542–47. doi:10.1097/MCC.0b013e328331a8a7. PMID 19713836. S2CID 19918811.
- Martí-Carvajal AJ, Solà I, Gluud C, Lathyris D, Cardona AF (December 2012). "Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients". The Cochrane Database of Systematic Reviews. 12: CD004388. doi:10.1002/14651858.CD004388.pub6. PMC 6464614. PMID 23235609.
- Boyd JH, Walley KR (August 2008). "Is there a role for sodium bicarbonate in treating lactic acidosis from shock?". Current Opinion in Critical Care. 14 (4): 379–83. doi:10.1097/MCC.0b013e3283069d5c. PMID 18614899. S2CID 22613993.
- Vincent, Jean-Louis; De Backer, Daniel (2013-10-31). Finfer, Simon R.; Vincent, Jean-Louis (eds.). "Circulatory Shock". New England Journal of Medicine. 369 (18): 1726–34. doi:10.1056/NEJMra1208943. ISSN 0028-4793. PMID 24171518. S2CID 6900105.
- Vincent JL, De Backer D (October 2013). "Circulatory shock". The New England Journal of Medicine. 369 (18): 1726–34. doi:10.1056/NEJMra1208943. PMID 24171518. S2CID 6900105.
- Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A (December 2014). "Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine". Intensive Care Medicine. 40 (12): 1795–815. doi:10.1007/s00134-014-3525-z. PMC 4239778. PMID 25392034.
- Irwin, Richard S.; Rippe, James M. (January 2003). Intensive Care Medicine. Lippincott Williams & Wilkins, Philadelphia & London. ISBN 978-0-7817-3548-3. Archived from the original on 2005-11-07.
- Cannon, Walter Bradford (1918). The Nature and Treatment of Wound Shock and Allied Conditions. American Medical Association.
- Bloch, Jack H.; Dietzman, Ronald H.; Pierce, Charles H.; Lillehei, Richard C. (April 1966). "Theories of the Production of Shock". British Journal of Anaesthesia. 38 (4): 234–49. doi:10.1093/bja/38.4.234. ISSN 0007-0912. PMID 5328405.